Navigation Links
Good Science from RegenceRx Equals Good Value for Michigan's Upper Peninsula Health Plan
Date:3/6/2013

PORTLAND, Ore., March 6, 2013 /PRNewswire/ -- Prescription medications are a key driver of the nation's rising health care costs, and many health care plans are seeking solutions that will provide the best value to their members. With that in mind, Michigan's Upper Peninsula Health Plan (UPHP) has selected RegenceRx to produce rigorous, independent evidence-based assessments of prescription medications, designed to support and maintain UPHP's formulary and medication coverage policies.

UPHP provides benefits to more than 30,000 Medicaid and MIChild members. It ranks among the top 25 Medicaid managed-care plans in the United States, according to the National Committee for Quality Assurance Medicaid Health Insurance Plan Rankings 2012–2013.

"We are honored that the UPHP has chosen RegenceRx as their partner in providing members with safe, effective and affordable medications. We look forward to helping them fulfill our shared commitment to providing cost efficient, quality health care to their members," said Raulo Frear , Pharm. D., general manager of RegenceRx.

"This partnership is a perfect fit for us, as RegenceRx shares the health plan's commitment to provide cost-efficient, high-quality health care to its members," said Sheryl Waudby , M.S., R. Ph., pharmacy director for the Upper Peninsula Health Plan. "We look forward to working with RegenceRx to support our formulary, the foundation of our pharmacy benefits program and our efforts to manage a value-based pharmacy benefit for our members." 

About RegenceRx
The mission of RegenceRx is to ensure that members have affordable coverage for prescription medications. The company is distinguished by its focus on clinical evidence to build its formulary, and its focus on lowest net costs has helped reduce the cost of prescription medications for RegenceRx and their members. RegenceRx currently provides PBM services for more than 1.2 million members of Regence Health Plans. In addition, over 7.7 million members from other Blue Cross and Blue Shield and Medicaid plans trust RegenceRx to provide clinical and contracting support. RegenceRx, Inc. is part of the Cambia Health Solutions family of companies.

About the Upper Peninsula Health Plan
Based in Marquette, Michigan, the Upper Peninsula Health Plan (UPHP) provides benefits to more than 30,000 Medicaid and MIChild members. With a network of more than 900 providers, UPHP also serves as the hub for all commercial managed-care and preferred provider organization (PPO) activity in the Upper Peninsula. UPHP ranks among the top 25 Medicaid managed-care plans in the United States, according to the National Committee for Quality Assurance Medicaid Health Insurance Plan Rankings 2012–2013.


'/>"/>
SOURCE RegenceRx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
2. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
3. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
4. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
5. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
6. Oregon Health & Science University Receives Award For Leadership In Advanced Healthcare Technology Solutions
7. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
8. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
9. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
10. AUL Files Seventh Brief Supporting First Amendment Freedom of Conscience
11. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
Breaking Medicine News(10 mins):